Cargando…

Improving bereavement outcomes in Zimbabwe: protocol for a feasibility cluster trial of the 9-cell bereavement tool

BACKGROUND: The high burden of bereavement in sub-Saharan Africa is largely attributable to HIV, cancer, and other non-communicable diseases. However, interventions to improve grief and bereavement are rare. Given high rates of mortality in the context of weak health systems, community lay members a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mutedzi, Barbara, Langhaug, Lisa, Hunt, Jennifer, Nkhoma, Kennedy, Harding, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509823/
https://www.ncbi.nlm.nih.gov/pubmed/31110775
http://dx.doi.org/10.1186/s40814-019-0450-5
_version_ 1783417325123272704
author Mutedzi, Barbara
Langhaug, Lisa
Hunt, Jennifer
Nkhoma, Kennedy
Harding, Richard
author_facet Mutedzi, Barbara
Langhaug, Lisa
Hunt, Jennifer
Nkhoma, Kennedy
Harding, Richard
author_sort Mutedzi, Barbara
collection PubMed
description BACKGROUND: The high burden of bereavement in sub-Saharan Africa is largely attributable to HIV, cancer, and other non-communicable diseases. However, interventions to improve grief and bereavement are rare. Given high rates of mortality in the context of weak health systems, community lay members are well placed to provide peer bereavement support. The 9-cell bereavement tool was developed in Zimbabwe to improve community members’ capacity to support the bereaved. This study aims to determine the feasibility of implementing the 9-cell bereavement tool and recruitment to experimental evaluation. METHODS/DESIGN: This feasibility cluster randomized trial with embedded qualitative interviews will be conducted in two comparable neighborhoods in Zimbabwe. Community leaders from each neighborhood will identify 25 potential community lay bereavement supporters, each of whom will recruit 2–3 bereaved community members into the trial. The intervention will be randomly allocated to one community, and the second community will form a wait-list control (n ≥ 75 in each community cluster). Recruitment is estimated to take place over 3 weeks. Measures at T0 (baseline, i.e., week 0), T1 (midline, i.e., week 14 or 3 months post-baseline) and T2 (endline, i.e., week 27 or 3 months post-midline) will address mental health, social support, and levels of grief per individual. Qualitative data will describe lay supporters’ views of intervention training and delivery, and participants’ experience of bereavement support. DISCUSSION: This is the first documented trial evaluating a bereavement intervention in sub-Saharan Africa. Recruitment, retention, and measurement data will determine the feasibility of a full trial. TRIAL REGISTRATION: ISRCTN, ISRCTN16484746. Registered 6 February 2018
format Online
Article
Text
id pubmed-6509823
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65098232019-05-20 Improving bereavement outcomes in Zimbabwe: protocol for a feasibility cluster trial of the 9-cell bereavement tool Mutedzi, Barbara Langhaug, Lisa Hunt, Jennifer Nkhoma, Kennedy Harding, Richard Pilot Feasibility Stud Study Protocol BACKGROUND: The high burden of bereavement in sub-Saharan Africa is largely attributable to HIV, cancer, and other non-communicable diseases. However, interventions to improve grief and bereavement are rare. Given high rates of mortality in the context of weak health systems, community lay members are well placed to provide peer bereavement support. The 9-cell bereavement tool was developed in Zimbabwe to improve community members’ capacity to support the bereaved. This study aims to determine the feasibility of implementing the 9-cell bereavement tool and recruitment to experimental evaluation. METHODS/DESIGN: This feasibility cluster randomized trial with embedded qualitative interviews will be conducted in two comparable neighborhoods in Zimbabwe. Community leaders from each neighborhood will identify 25 potential community lay bereavement supporters, each of whom will recruit 2–3 bereaved community members into the trial. The intervention will be randomly allocated to one community, and the second community will form a wait-list control (n ≥ 75 in each community cluster). Recruitment is estimated to take place over 3 weeks. Measures at T0 (baseline, i.e., week 0), T1 (midline, i.e., week 14 or 3 months post-baseline) and T2 (endline, i.e., week 27 or 3 months post-midline) will address mental health, social support, and levels of grief per individual. Qualitative data will describe lay supporters’ views of intervention training and delivery, and participants’ experience of bereavement support. DISCUSSION: This is the first documented trial evaluating a bereavement intervention in sub-Saharan Africa. Recruitment, retention, and measurement data will determine the feasibility of a full trial. TRIAL REGISTRATION: ISRCTN, ISRCTN16484746. Registered 6 February 2018 BioMed Central 2019-05-10 /pmc/articles/PMC6509823/ /pubmed/31110775 http://dx.doi.org/10.1186/s40814-019-0450-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Mutedzi, Barbara
Langhaug, Lisa
Hunt, Jennifer
Nkhoma, Kennedy
Harding, Richard
Improving bereavement outcomes in Zimbabwe: protocol for a feasibility cluster trial of the 9-cell bereavement tool
title Improving bereavement outcomes in Zimbabwe: protocol for a feasibility cluster trial of the 9-cell bereavement tool
title_full Improving bereavement outcomes in Zimbabwe: protocol for a feasibility cluster trial of the 9-cell bereavement tool
title_fullStr Improving bereavement outcomes in Zimbabwe: protocol for a feasibility cluster trial of the 9-cell bereavement tool
title_full_unstemmed Improving bereavement outcomes in Zimbabwe: protocol for a feasibility cluster trial of the 9-cell bereavement tool
title_short Improving bereavement outcomes in Zimbabwe: protocol for a feasibility cluster trial of the 9-cell bereavement tool
title_sort improving bereavement outcomes in zimbabwe: protocol for a feasibility cluster trial of the 9-cell bereavement tool
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509823/
https://www.ncbi.nlm.nih.gov/pubmed/31110775
http://dx.doi.org/10.1186/s40814-019-0450-5
work_keys_str_mv AT mutedzibarbara improvingbereavementoutcomesinzimbabweprotocolforafeasibilityclustertrialofthe9cellbereavementtool
AT langhauglisa improvingbereavementoutcomesinzimbabweprotocolforafeasibilityclustertrialofthe9cellbereavementtool
AT huntjennifer improvingbereavementoutcomesinzimbabweprotocolforafeasibilityclustertrialofthe9cellbereavementtool
AT nkhomakennedy improvingbereavementoutcomesinzimbabweprotocolforafeasibilityclustertrialofthe9cellbereavementtool
AT hardingrichard improvingbereavementoutcomesinzimbabweprotocolforafeasibilityclustertrialofthe9cellbereavementtool